Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL (2011) Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst 103:1461–1468
Article
CAS
PubMed
PubMed Central
Google Scholar
Ahern TP, Lash TL, Damkier P, Christiansen PM, Cronin-Fenton DP (2014) Statins and breast cancer prognosis: evidence and opportunities. Lancet Oncol 15:e461–e468
Article
CAS
PubMed
PubMed Central
Google Scholar
Bonovas S, Filioussi K, Tsavaris N, Sitaras NM (2005) Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies. J Clin Oncol 23:8606–8612
Article
PubMed
Google Scholar
Boudreau DM, Gardner JS, Malone KE, Heckbert SR, Blough DK, Daling JR (2004) The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case–control study. Cancer 100:2308–2316
Article
CAS
PubMed
Google Scholar
Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR (2007) Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomark Prev 16:416–421
Article
CAS
Google Scholar
Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC (2006) Breast cancer growth prevention by statins. Cancer Res 66:8707–8714
Article
CAS
PubMed
Google Scholar
Cancer research UK (2013) Breast cancer incidence statistics. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/. Accessed 20 Nov 2013
Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT, Women’s Health Initiative Research Group (2006) Statin use and breast cancer: prospective results from the Women’s Health Initiative. J Natl Cancer Inst 98:700–707
Article
CAS
PubMed
Google Scholar
Chajes V, Romieu I (2014) Nutrition and breast cancer. Maturitas 77:7–11
Article
CAS
PubMed
Google Scholar
Chan TF, Wu CH, Lin CL, Yang CY (2014) Statin use and the risk of breast cancer: a population-based case–control study. Expert Opin Drug Saf 13:287–293
Article
CAS
PubMed
Google Scholar
Cho KJ, Hill MM, Chigurupati S, Du G, Parton RG, Hancock JF (2011) Therapeutic levels of the hydroxmethylglutaryl-coenzyme A reductase inhibitor lovastatin activate Ras signaling via phospholipase D2. Mol Cell Biol 31:1110–1120
Article
CAS
PubMed
PubMed Central
Google Scholar
Corsini A, Maggi FM, Catapano AL (1995) Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacol Res 31:9–27
Article
CAS
PubMed
Google Scholar
Dale KM, Coleman CI, Henyan NN, Kluger J, White CM (2006) Statins and cancer risk: a meta-analysis. JAMA 295:74–80
Article
CAS
PubMed
Google Scholar
Denoyelle C, Vasse M, Körner M, Mishal Z, Ganné F, Vannier JP, Soria J, Soria C (2001) Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study. Carcinogenesis 22:1139–1148
Article
CAS
PubMed
Google Scholar
Desai P, Chlebowski R, Cauley JA, Manson JE, Wu C, Martin LW, Jay A, Bock C, Cote M, Petrucelli N, Rosenberg CA, Peters U, Agalliu I, Budrys N, Abdul-Hussein M, Lane D, Luo J, Park HL, Thomas F, Wactawski-Wende J, Simon MS (2013) Prospective analysis of association between statin use and breast cancer risk in the women’s health initiative. Cancer Epidemiol Biomark Prev 22:1868–1876
Article
CAS
Google Scholar
DeSantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics, 2011. CA Cancer J Clin 61:409–418
Article
PubMed
Google Scholar
Dimitroulakos J, Ye LY, Benzaquen M, Moore MJ, Kamel-Reid S, Freedman MH, Yeger H, Penn LZ (2001) Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications. Clin Cancer Res 7:158–167
CAS
PubMed
Google Scholar
Eaton M, Eklof J, Beal JR, Sahmoun AE (2009) Statins and breast cancer in postmenopausal women without hormone therapy. Anticancer Res 29:5143–5148
CAS
PubMed
Google Scholar
Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2005) Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med 165:2264–2271
Article
CAS
PubMed
Google Scholar
Health promotion Administration, Ministry of Health and Welfare (2010) Cancer Registry Report 2010. http://www.hpa.gov.tw/. Accessed 1 June 2013
Higgins MJ, Prowell TM, Blackford AL, Byrne C, Khouri NF, Slater SA, Jeter SC, Armstrong DK, Davidson NE, Emens LA, Fetting JH, Powers PP, Wolff AC, Green H, Thibert JN, Rae JM, Folkerd E, Dowsett M, Blumenthal RS, Garber JE, Stearns V (2012) A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer. Breast Cancer Res Treat 131:915–924
Article
CAS
PubMed
Google Scholar
International Agency for Research on Cancer (2010) Glogocan 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No.10 Lyon, France: IARC 2010. http://globocan.iarc.fr. Published 2010. Accessed 20 Nov 2013
Jafari M, Rezaei M, Kalantari H, Hashemitabar M (2013) Determination of cell death induced by lovastatin on human colon cell line HT29 using the comet assay. Jundishapur J Nat Pharm Prod 8:187–191
Article
PubMed
PubMed Central
Google Scholar
Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60:277–300
Article
PubMed
Google Scholar
Kang S, Kim ES, Moon A (2009) Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras. Oncol Rep 21:1317–1322
PubMed
Google Scholar
Klawitter J, Shokati T, Moll V, Christians U, Klawitter J (2010) Effects of lovastatin on breast cancer cells: a proteo-metabonomic study. Breast Cancer Res 12:R16
Article
CAS
PubMed
PubMed Central
Google Scholar
Koga T, Shimada Y, Kuroda M, Tsujita Y, Hasegawa K, Yamazaki M (1990) Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Biochim Biophys Acta 1045:115–120
Article
CAS
PubMed
Google Scholar
Kwan ML, Habel LA, Flick ED, Quesenberry CP, Caan B (2008) Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat 109:573–579
Article
CAS
PubMed
Google Scholar
Li WC, Lin TK, Wang SP, Chang CJ (2010) A review of dyslipidemia management and antilipidemic agents. Formosa J Clin Pharm 18:79–88
Google Scholar
Ma L, Niknejad N, Gorn-Hondermann I, Dayekh K, Dimitroulakos J (2012) Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells. PLoS ONE 7:e46055
Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Ng HT (2011) Breast Cancer Concept Female Cancer Foundation, Female Cancer Foundation. http://www.femalecancer.org.tw. Accessed 20 Aug 2013
Niknejad N, Morley M, Dimitroulakos J (2007) Activation of the integrated stress response regulates lovastatin-induced apoptosis. J Biol Chem 282:29748–29756
Article
CAS
PubMed
Google Scholar
Niknejad N, Gorn-Hondermann I, Ma L, Zahr S, Johnson-Obeseki S, Corsten M, Dimitroulakos J (2014) Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal. Int J Cancer 134:268–279
Article
CAS
PubMed
Google Scholar
Pocobelli G, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan KM (2008) Statin use and risk of breast cancer. Cancer 112:27–33
Article
PubMed
Google Scholar
Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139
Article
PubMed
Google Scholar
Tsujita Y, Kuroda M, Shimada Y, Tanzawa K, Arai M, Kaneko I, Tanaka M, Masuda H, Tarumi C, Watanabe Y, Fujii S (1986) CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim Biophys Acta 877:50–60
Article
CAS
PubMed
Google Scholar
Undela K, Srikanth V, Bansal D (2012) Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast Cancer Res Treat 135:261–269
Article
CAS
PubMed
Google Scholar
Woditschka S, Habel LA, Udaltsova N, Friedman GD, Sieh W (2010) Lipophilic statin use and risk of breast cancer subtypes. Cancer Epidemiol Biomark Prev 19:2479–2487
Article
CAS
Google Scholar